Researchers in Taiwan have developed a new targeted therapy drug that preclinical trials suggest could inhibit the growth of tumors in nearly 30 percent of cancer patients.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Power restored for 94% of homes hit by typhoon-caused record damage
07/10/2025 07:55 PM - Politics
Referendum, 26 recall votes could cost up to NT$1.62 billion: CEC
07/10/2025 07:42 PM - Politics
Ex-President Tsai never intervened in green energy projects: Office
07/10/2025 06:11 PM - Society
Taiwan sees 18th consecutive month of population decline
07/10/2025 05:35 PM - Politics
NATO chief sounds alarm over China's ambition of taking Taiwan
07/10/2025 05:33 PM